Regeneron Eylea is a commonly used treatment for various eye conditions, including age-related macular degeneration and diabetic macular edema. Here are 10 things you should know about this medication:
- Eylea is an injection that is administered into the eye by a healthcare professional.
- It works by blocking a protein called vascular endothelial growth factor (VEGF) that can cause abnormal blood vessel growth in the eye.
- Regeneron Eylea is approved by the FDA for the treatment of wet age-related macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion.
- The most common side effects of Eylea include temporary vision changes, eye pain, and redness or irritation at the injection site.
- Patients may need to receive multiple injections of Eylea over the course of several months to achieve the desired results.
- It is important to follow your healthcare provider's instructions for receiving Eylea injections and attending follow-up appointments.
- Some patients may experience improved vision after receiving Eylea treatment, while others may have more stable vision or slower progression of their eye condition.
- Regeneron Eylea is not a cure for eye diseases, but it can help to manage symptoms and improve quality of life for many patients.
- Before starting Eylea treatment, be sure to discuss any other medical conditions or medications you are taking with your healthcare provider.
- If you have any concerns or questions about Eylea treatment, don't hesitate to talk to your eye doctor or specialist for more information.